- Home
- JG vs MAIA Comparison
JG vs MAIA Comparison
Compare JG & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JG
- MAIA
- Stock Information
- Founded
- JG 2012
- MAIA 2018
- Country
- JG China
- MAIA United States
- Employees
- JG N/A
- MAIA N/A
- Industry
- JG Computer Software: Programming Data Processing
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- JG Technology
- MAIA Health Care
- Exchange
- JG Nasdaq
- MAIA Nasdaq
- Market Cap
- JG 50.0M
- MAIA 44.8M
- IPO Year
- JG 2018
- MAIA 2022
- Fundamental
- Price
- JG $8.29
- MAIA $1.55
- Analyst Decision
- JG
- MAIA
- Analyst Count
- JG 0
- MAIA 0
- Target Price
- JG N/A
- MAIA N/A
- AVG Volume (30 Days)
- JG 32.7K
- MAIA 75.2K
- Earning Date
- JG 06-05-2025
- MAIA 05-13-2025
- Dividend Yield
- JG N/A
- MAIA N/A
- EPS Growth
- JG N/A
- MAIA N/A
- EPS
- JG N/A
- MAIA N/A
- Revenue
- JG $43,316,299.00
- MAIA N/A
- Revenue This Year
- JG $10.90
- MAIA N/A
- Revenue Next Year
- JG N/A
- MAIA N/A
- P/E Ratio
- JG N/A
- MAIA N/A
- Revenue Growth
- JG 8.94
- MAIA N/A
- 52 Week Low
- JG $2.36
- MAIA $1.40
- 52 Week High
- JG $20.94
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- JG 40.56
- MAIA 46.60
- Support Level
- JG $7.79
- MAIA $1.41
- Resistance Level
- JG $9.00
- MAIA $1.61
- Average True Range (ATR)
- JG 0.59
- MAIA 0.11
- MACD
- JG -0.12
- MAIA 0.01
- Stochastic Oscillator
- JG 16.56
- MAIA 62.50
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.